Condition
Visual Outcomes
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03351894Not ApplicableCompletedPrimary
Comparison of Clinical Outcomes in Ziemer Femtosecond Versus Conventional Phacoemulsification Surgery
NCT06590272Completed
Comparison on Outcomes of Four IOLs in Patients With Cataracts
NCT00758940Phase 4WithdrawnPrimary
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
NCT00821223Not ApplicableCompletedPrimary
Outcome Following Phacoemulsification Versus Small Incision Cataract Surgery (SICS)
Showing all 4 trials